Centiva Capital’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,573
Closed -$177K 1801
2024
Q2
$177K Buy
+13,573
New +$177K ﹤0.01% 1271
2023
Q4
Sell
-3,053
Closed -$61.4K 1466
2023
Q3
$61.4K Buy
3,053
+873
+40% +$17.5K ﹤0.01% 1107
2023
Q2
$58.5K Buy
+2,180
New +$58.5K ﹤0.01% 1101
2021
Q3
Sell
-1,360
Closed -$211K 1100
2021
Q2
$211K Buy
+1,360
New +$211K 0.01% 895